はじめに：アンドロジェニック・パラダイムの再考
テストステロンは生物学的・社会的・心理的領域を横断する稀有な分子である。一般に「男性ホルモン」と単純化されがちだが、その影響範囲は身体構造から認知機能、社会的行動パターン、さらには集団進化力学にまで及ぶ。本シリーズでは、テストステロンに関する最新の科学的知見を概観するとともに、従来の理解の枠を超えた革新的視点を提示する。
現代社会における環境変化、ライフスタイルの変容、そして急速な技術進歩は、テストステロン研究に新たな問いを投げかけている。特に環境化学物質の内分泌撹乱作用、慢性的ストレス環境、デジタル時代の社会的相互作用パターンの変化は、ホルモン動態の伝統的理解に再考を促している。
本シリーズは以下の5部構成となる：
- 分子から生体システムへ - テストステロンの分子生物学と統合生理学
- 身体機能と代謝制御 - 筋骨格系・代謝系への多層的影響
- 脳・行動科学の新地平 - 神経内分泌学と行動生物学の接点
- 社会進化と文明の内分泌学 - 集団動態とテストステロン環境
- 未来医療と最適化戦略 - 精密医療からバイオハッキングまで
各記事は独立して読み進められるよう構成されているが、全体を通読することで、より立体的な理解が得られるだろう。科学的厳密性を保ちつつも、従来の教科書的記述にとどまらない革新的視点を随所に織り込んでいる。
現代の知的読者にとって、テストステロンの理解は単なる生物学的知識を超え、自己最適化、社会設計、そして種としての将来を考察する上での重要な視座となるはずだ。
なお、各記事の参考文献はこのページの最後に集約して掲載することにした。
そして、注意として「革新的視点」の記述は、完全にオリジナルというわけではなく
- 既存の研究データから導かれる可能性がある解釈や仮説
- 複数の研究分野のデータを統合した新しい概念的枠組みや取り組み
- 最先端の研究者の間で議論され始めている萌芽的アイデア
つまり、既存の研究データや理論を新しい角度から再解釈し、異なる学問分野を横断するように統合し発展させたものだ。
例えば「内分泌的共進化」「階層的ホルモン流体力学」「意味的内分泌学」「化学的社会彫刻」「シグナル生態学的設計」などの概念は、個別の研究知見に基づきながらも、それらを新たな概念的枠組みで体系化している。これらのような視点は科学的に完全に検証された事実というよりは、刺激的な思考実験や将来の研究方向性を示唆する統合的仮説やモデルと考えてくれるとありがたい。
一部の前衛的研究者の間では類似の考え方が議論されているだろうが、このような体系的な形で統合され精緻化されてはおらず、一般の研究コミュニティではまだ広く共有されていない視点だという意味で価値あるものと考える。
本シリーズの全体像
第1部：分子から生体システムへ
テストステロンの分子構造、生合成経路、受容体機構から、全身性の恒常性維持システムまでを探究する。特に、非古典的経路と新たに発見された制御機構に焦点を当てる。
第2部：身体機能と代謝制御
筋肉合成、骨密度維持、脂質代謝、エネルギー分配におけるテストステロンの多面的役割を検証する。特に年齢依存的変化と適応メカニズムについて深掘りする。
第3部：脳・行動科学の新地平
テストステロンが認知機能、意思決定過程、社会的階層形成、リスク評価に及ぼす影響を最新の神経科学知見から考察する。特に社会的文脈依存性と可塑性に注目する。
第4部：社会進化と文明の内分泌学
産業化、都市化、デジタル化がテストステロン動態に与える影響と、それが社会構造と文明の進化方向性に及ぼす長期的影響を探る。特に世代間変化と適応機構を検討する。
第5部：未来医療と最適化戦略
低テストステロン症の新規治療法、ホルモン最適化技術、精密医療アプローチ、そして倫理的・社会的課題を展望する。特にパーソナライズド介入と予防医学的視点を重視する。
各部は単独で読むことも可能だが、通読することで、微視的な分子メカニズムから巨視的な社会進化まで、一貫した理解の枠組みが得られるよう設計されている。
テストステロン研究の参考文献
基礎研究と分子メカニズム
Aranda, A., & Pascual, A. (2001). Nuclear hormone receptors and gene expression. Physiological Reviews, 81(3), 1269-1304.
Bhasin, S., Travison, T. G., & Storer, T. W. (2017). Testosterone and aging: Clinical research directions. The Journal of Clinical Endocrinology & Metabolism, 102(4), 1161-1173.
Chang, C., Lee, S. O., Wang, R. S., Yeh, S., & Chang, T. M. (2013). Androgen receptor (AR) physiological roles in male and female reproductive systems: Lessons learned from AR-knockout mice lacking AR in selective cells. Biology of Reproduction, 89(1), 21.
Choi, S. M., & Lee, B. M. (2015). Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids. Expert Opinion on Drug Safety, 14(11), 1773-1785.
Davey, R. A., & Grossmann, M. (2016). Androgen receptor structure, function and biology: From bench to bedside. The Clinical Biochemist Reviews, 37(1), 3-15.
Fargo, K. N., Foecking, E. M., Jones, K. J., & Sengelaub, D. R. (2009). Neuroprotective actions of androgens on motoneurons. Frontiers in Neuroendocrinology, 30(2), 130-141.
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008). Non-genomic actions of androgens. Frontiers in Neuroendocrinology, 29(2), 169-181.
Handelsman, D. J. (2020). Androgen physiology, pharmacology, and abuse. In K. R. Feingold et al. (Eds.), Endotext. MDText.com, Inc.
Handa, R. J., & Weiser, M. J. (2014). Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis. Frontiers in Neuroendocrinology, 35(2), 197-220.
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001). Longitudinal effects of aging on serum total and free testosterone levels in healthy men. The Journal of Clinical Endocrinology & Metabolism, 86(2), 724-731.
Jin, J. M., & Yang, W. X. (2014). Molecular regulation of hypothalamus-pituitary-gonads axis in males. Gene, 551(1), 15-25.
Mooradian, A. D., Morley, J. E., & Korenman, S. G. (1987). Biological actions of androgens. Endocrine Reviews, 8(1), 1-28.
Nantermet, P. V., Xu, J., Yu, Y., Hodor, P., Holder, D., Adamski, S., Gentile, M. A., Kimmel, D. B., Harada, S.-i., Gerhold, D., Freedman, L. P., & Ray, W. J. (2004). Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. Journal of Biological Chemistry, 279(2), 1310-1322.
O'Hara, L., & Smith, L. B. (2015). Androgen receptor roles in spermatogenesis and infertility. Best Practice & Research Clinical Endocrinology & Metabolism, 29(4), 595-605.
Rastrelli, G., Corona, G., & Maggi, M. (2018). Testosterone and sexual function in men. Maturitas, 112, 46-52.
Smith, L. B., & Walker, W. H. (2014). The regulation of spermatogenesis by androgens. Seminars in Cell & Developmental Biology, 30, 2-13.
Verhoeven, G., Willems, A., Denolet, E., Swinnen, J. V., & De Gendt, K. (2010). Androgens and spermatogenesis: Lessons from transgenic mouse models. Philosophical Transactions of the Royal Society B: Biological Sciences, 365(1546), 1537-1556.
Walker, W. H. (2011). Testosterone signaling and the regulation of spermatogenesis. Spermatogenesis, 1(2), 116-120.
Wang, C., Liu, Y., & Cao, J. M. (2014). G protein-coupled receptors: Extranuclear mediators for the non-genomic actions of steroids. International Journal of Molecular Sciences, 15(9), 15412-15425.
Wilson, J. D. (2001). The role of 5α-reduction in steroid hormone physiology. Reproduction, Fertility and Development, 13(7-8), 673-678.
代謝と身体機能
Antonio, L., Wu, F. C. W., O'Neill, T. W., Pye, S. R., Carter, E. L., Finn, J. D., Rutter, M. K., Laurent, M. R., Huhtaniemi, I. T., Han, T. S., Lean, M. E. J., Keevil, B. G., Pendleton, N., Rastrelli, G., Forti, G., Bartfai, G., Casanueva, F. F., Kula, K., Punab, M., … Vanderschueren, D. (2016). Associations between sex steroids and the development of metabolic syndrome: A longitudinal study in European men. Journal of Clinical Endocrinology & Metabolism, 101(4), 1754-1764.
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine, 335(1), 1-7.
Corona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016). Testosterone supplementation and body composition: Results from a meta-analysis of observational studies. Journal of Endocrinological Investigation, 39(9), 967-981.
Crisóstomo, L., Almeida, M., & Sousa, M. (2022). Metabolic syndrome and hypogonadism—Two peas in a pod. International Journal of Molecular Sciences, 23(3), 1253.
Dhindsa, S., Ghanim, H., Batra, M., & Dandona, P. (2018). Hypogonadotropic hypogonadism in men with diabesity. Diabetes Care, 41(7), 1516-1525.
Dubois, V., Laurent, M. R., Jardi, F., Antonio, L., Lemaire, K., Goyvaerts, L., Deldicque, L., Carmeliet, G., Decallonne, B., Vanderschueren, D., & Claessens, F. (2016). Androgen deficiency exacerbates high-fat diet-induced metabolic alterations in male mice. Endocrinology, 157(2), 648-665.
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002). Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology & Metabolism, 87(2), 589-598.
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., & Leder, B. Z. (2013). Gonadal steroids and body composition, strength, and sexual function in men. New England Journal of Medicine, 369(11), 1011-1022.
Grossmann, M., Matsumoto, A. M. (2017). A perspective on middle-aged and older men with functional hypogonadism: Focus on holistic management. Journal of Clinical Endocrinology & Metabolism, 102(3), 1067-1075.
Kelly, D. M., & Jones, T. H. (2013). Testosterone: A metabolic hormone in health and disease. Journal of Endocrinology, 217(3), R25-R45.
Laurent, M. R., Hammond, G. L., Blokland, M., Jardí, F., Antonio, L., Dubois, V., Khalil, R., Sterk, S. S., Gielen, E., Decallonne, B., Carmeliet, G., Kaufman, J. M., Fiers, T., Huhtaniemi, I. T., Vanderschueren, D., & Claessens, F. (2016). Sex hormone-binding globulin regulation of androgen bioactivity in vivo: Validation of the free hormone hypothesis. Scientific Reports, 6(1), 35539.
Lee, W.-S., Kim, J., Yun, T., Kang, Y. R., Kim, J. Y., Cha, H. J., Kim, S.-I., Arum Yoon, H., Jo, H., & Hwang, W. (2022). Testosterone induces mitochondrial respiration by activating cytochrome c oxidase subunit 1 transcription. Cell Death & Disease, 13(2), 120.
Mouser, J. G., Loprinzi, P. D., & Loenneke, J. P. (2016). The association between physiologic testosterone levels, lean mass, and fat mass in a nationally representative sample of men in the United States. Steroids, 115, 62-66.
O'Connell, M. D. L., & Wu, F. C. W. (2014). Androgen effects on skeletal muscle: Implications for the development and management of frailty. Asian Journal of Andrology, 16(2), 203-212.
Rajender, S., Rahul, P., & Mahdi, A. A. (2010). Mitochondria, spermatogenesis and male infertility. Mitochondrion, 10(5), 419-428.
Saad, F., Röhrig, G., von Haehling, S., & Traish, A. (2017). Testosterone deficiency and testosterone treatment in older men. Gerontology, 63(2), 144-156.
Shores, M. M., Smith, N. L., Forsberg, C. W., Anawalt, B. D., & Matsumoto, A. M. (2012). Testosterone treatment and mortality in men with low testosterone levels. The Journal of Clinical Endocrinology & Metabolism, 97(6), 2050-2058.
Storer, T. W., Basaria, S., Traustadóttir, T., Harman, S. M., Pencina, K., Li, Z., Travison, T. G., Miciek, R., Tsitouras, P., Hally, K., Huang, G., & Bhasin, S. (2017). Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men. Journal of Clinical Endocrinology & Metabolism, 102(2), 583-593.
Traish, A. M. (2014). Adverse health effects of testosterone deficiency (TD) in men. Toxicologic Pathology, 42(1), 88-105.
Travison, T. G., Araujo, A. B., Kupelian, V., O'Donnell, A. B., & McKinlay, J. B. (2007). The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology & Metabolism, 92(2), 549-555.
Tyagi, V., Scordo, M., Yoon, R. S., Liporace, F. A., & Greene, L. W. (2017). Revisiting the role of testosterone: Are we missing something? Reviews in Urology, 19(1), 16-24.
神経科学と行動研究
Aarts, H., & van Honk, J. (2009). Testosterone and unconscious positive priming increase human motivation separately. Neuroreport, 20(14), 1300-1303.
Bos, P. A., Panksepp, J., Bluthé, R. M., & van Honk, J. (2012). Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: A review of single administration studies. Frontiers in Neuroendocrinology, 33(1), 17-35.
Celec, P., Ostatníková, D., & Hodosy, J. (2015). On the effects of testosterone on brain behavioral functions. Frontiers in Neuroscience, 9, 12.
Carre, J. M., & Archer, J. (2018). Testosterone and human behavior: The role of individual and contextual variables. Current Opinion in Psychology, 19, 149-153.
Carre, J. M., Geniole, S. N., Ortiz, T. L., Bird, B. M., Videto, A., & Bonin, P. L. (2017). Exogenous testosterone rapidly increases aggressive behavior in dominant and impulsive men. Biological Psychiatry, 82(4), 249-256.
Cho, J. H., Song, S. B., Kim, M. J., Kang, S., Kim, W., Choi, S. Y., Kang, M., Lee, K. H., & Yu, K. (2022). The distinct roles of androgen receptor in non-neuronal cells and neurons for regulating anxiety and feeding behaviors in males. Molecular Psychiatry, 27(4), 2240-2253.
Eisenegger, C., Haushofer, J., & Fehr, E. (2011). The role of testosterone in social interaction. Trends in Cognitive Sciences, 15(6), 263-271.
Eisenegger, C., Naef, M., Snozzi, R., Heinrichs, M., & Fehr, E. (2010). Prejudice and truth about the effect of testosterone on human bargaining behaviour. Nature, 463(7279), 356-359.
Geniole, S. N., & Carré, J. M. (2018). Human social neuroendocrinology: Review of the rapid effects of testosterone. Hormones and Behavior, 104, 192-205.
Goetz, S. M. M., Tang, L., Thomason, M. E., Diamond, M. P., Hariri, A. R., & Carré, J. M. (2014). Testosterone rapidly increases neural reactivity to threat in healthy men: A novel two-step pharmacological challenge paradigm. Biological Psychiatry, 76(4), 324-331.
Hagger-Johnson, G., Heathcote, L. C., Bremner, S. A., & Tan, S. S. (2022). Unravelling the mechanisms linking testosterone with risk-taking: A systematic review. Hormones and Behavior, 146, 105236.
Heany, S. J., van Honk, J., Stein, D. J., & Brooks, S. J. (2016). A quantitative and qualitative review of the effects of testosterone on the function and structure of the human social-emotional brain. Metabolic Brain Disease, 31(1), 157-167.
Höfer, P., Lanzenberger, R., & Kasper, S. (2013). Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacology. European Neuropsychopharmacology, 23(2), 79-88.
Josephs, R. A., Newman, M. L., Brown, R. P., & Beer, J. M. (2003). Status, testosterone, and human intellectual performance: Stereotype threat as status concern. Psychological Science, 14(2), 158-163.
Mahmoud, R., Wainwright, S. R., & Galea, L. A. M. (2016). Sex hormones and adult hippocampal neurogenesis: Regulation, implications, and potential mechanisms. Frontiers in Neuroendocrinology, 41, 129-152.
McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014). Sex differences in anxiety and depression: Role of testosterone. Frontiers in Neuroendocrinology, 35(1), 42-57.
Montoya, E. R., Bos, P. A., Terburg, D., Rosenberger, L. A., & van Honk, J. (2014). Cortisol administration induces global down-regulation of the brain's reward circuitry. Psychoneuroendocrinology, 47, 31-42.
Nave, G., Nadler, A., Zava, D., & Camerer, C. (2017). Single-dose testosterone administration impairs cognitive reflection in men. Psychological Science, 28(10), 1398-1407.
Newman, M. L., Sellers, J. G., & Josephs, R. A. (2005). Testosterone, cognition, and social status. Hormones and Behavior, 47(2), 205-211.
Roney, J. R., & Gettler, L. T. (2015). The role of testosterone in human romantic relationships. Current Opinion in Psychology, 1, 81-86.
Sarkar, P., Bergman, K., Fisk, N. M., O'Connor, T. G., & Glover, V. (2007). Amniotic fluid testosterone: Relationship with cortisol and gestational age. Clinical Endocrinology, 67(5), 743-747.
Terburg, D., & van Honk, J. (2013). Approach-avoidance versus dominance-submissiveness: A multilevel neural framework on how testosterone promotes social status. Emotion Review, 5(3), 296-302.
Tyborowska, A., Volman, I., Niermann, H. C. M., Pouwels, J. L., Smeekens, S., Cillessen, A. H. N., Toni, I., & Roelofs, K. (2018). Early-life and pubertal stress differentially modulate grey matter development in human adolescents. Scientific Reports, 8(1), 9201.
van Honk, J., Schutter, D. J., Bos, P. A., Kruijt, A.-W., Lentjes, E. G., & Baron-Cohen, S. (2011). Testosterone administration impairs cognitive empathy in women depending on second-to-fourth digit ratio. Proceedings of the National Academy of Sciences, 108(8), 3448-3452.
Volman, I., Toni, I., Verhagen, L., & Roelofs, K. (2011). Endogenous testosterone modulates prefrontal-amygdala connectivity during social emotional behavior. Cerebral Cortex, 21(10), 2282-2290.
Welling, L. L. M., Moreau, B. J. P., Bird, B. M., Hansen, S., & Carré, J. M. (2019). Exogenous testosterone increases men's perceptions of their own physical dominance. Psychoneuroendocrinology, 110, 104411.
Wibral, M., Dohmen, T., Klingmüller, D., Weber, B., & Falk, A. (2012). Testosterone administration reduces lying in men. PLoS ONE, 7(10), e46774.
Wood, R. I., Armstrong, A., Fridkin, V., Shah, V., Najafi, A., & Jakowec, M. (2013). 'Roid rage in rats? Testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylase. Physiology & Behavior, 110-111, 6-12.
Zak, P. J., Kurzban, R., Ahmadi, S., Swerdloff, R. S., Park, J., Efremidze, L., Redwine, K., Morgan, K., & Matzner, W. (2009). Testosterone administration decreases generosity in the ultimatum game. PLoS ONE, 4(12), e8330.
社会科学と人類学研究
Archer, J. (2006). Testosterone and human aggression: An evaluation of the challenge hypothesis. Neuroscience & Biobehavioral Reviews, 30(3), 319-345.
Bird, B. M., Geniole, S. N., Little, A. C., Moreau, B. J. P., Ortiz, T. L., Goldfarb, B., Bonin, P. L., & Carré, J. M. (2019). Does exogenous testosterone modulate men's ratings of facial dominance or trustworthiness? Adaptive Human Behavior and Physiology, 5(4), 365-381.
Burnham, T. C. (2007). High-testosterone men reject low ultimatum game offers. Proceedings of the Royal Society B: Biological Sciences, 274(1623), 2327-2330.
Carré, J. M., & McCormick, C. M. (2008). Aggressive behavior and change in salivary testosterone concentrations predict willingness to engage in a competitive task. Hormones and Behavior, 54(3), 403-409.
Gettler, L. T., McDade, T. W., Feranil, A. B., & Kuzawa, C. W. (2011). Longitudinal evidence that fatherhood decreases testosterone in human males. Proceedings of the National Academy of Sciences, 108(39), 16194-16199.
Gray, P. B., McHale, T. S., & Carré, J. M. (2017). A review of human male field studies of hormones and behavioral reproductive effort. Hormones and Behavior, 91, 52-67.
Grebe, N. M., Del Giudice, M., Thompson, M. E., Nickels, N., Ponzi, D., Zilioli, S., Maestripieri, D., & Gangestad, S. W. (2019). Testosterone, cortisol, and status-striving personality features: A review and empirical evaluation of the Dual Hormone hypothesis. Hormones and Behavior, 109, 25-37.
Kornienko, O., Clemans, K. H., Out, D., & Granger, D. A. (2014). Hormone behavior associations in early adolescence: Testosterone and estradiol methodological considerations and links with cortisol. Developmental Psychobiology, 56(6), 1197-1211.
Little, A. C., Jones, B. C., & DeBruine, L. M. (2011). Facial attractiveness: Evolutionary based research. Philosophical Transactions of the Royal Society B: Biological Sciences, 366(1571), 1638-1659.
Marečková, K., Jiang, H., Pospisil, J., Jolly, J., Zhu, L., Su, L., & Tseng, W. L. (2022). Social status-seeking relates to testosterone, cortisol, and amygdala activity during social evaluation. Social Cognitive and Affective Neuroscience, 17(7), 701-711.
Muehlenbein, M. P., & Bribiescas, R. G. (2005). Testosterone-mediated immune functions and male life histories. American Journal of Human Biology, 17(5), 527-558.
Pearson, M., & Schipper, B. C. (2013). Menstrual cycle and competitive bidding. Games and Economic Behavior, 78, 1-20.
Puts, D. A., Pope, L. E., Hill, A. K., Cárdenas, R. A., Welling, L. L. M., Wheatley, J. R., & Breedlove, S. M. (2015). Fulfilling desire: Evidence for negative feedback between men's testosterone, sociosexual psychology, and sexual partner number. Hormones and Behavior, 70, 14-21.
Ronay, R., & Carney, D. R. (2013). Testosterone's negative relationship with empathic accuracy and perceived leadership ability. Social Psychological and Personality Science, 4(1), 92-99.
Ronay, R., & von Hippel, W. (2010). Power, testosterone, and risk-taking. Journal of Behavioral Decision Making, 23(5), 473-482.
Sapolsky, R. M. (2005). The influence of social hierarchy on primate health. Science, 308(5722), 648-652.
Sollberger, S., & Ehlert, U. (2016). How to use and interpret hormone ratios. Psychoneuroendocrinology, 63, 385-397.
Stanton, S. J. (2017). The role of testosterone and estrogen in consumer behavior and social and economic decision making: A review. Hormones and Behavior, 92, 155-163.
Stanton, S. J., Beehner, J. C., Saini, E. K., Kuhn, C. M., & LaBar, K. S. (2009). Dominance, politics, and physiology: Voters' testosterone changes on the night of the 2008 United States presidential election. PLoS ONE, 4(10), e7543.
Trumble, B. C., Blackwell, A. D., Stieglitz, J., Thompson, M. E., Suarez, I. M., Kaplan, H., & Gurven, M. (2016). Associations between male testosterone and immune function in a pathogenically stressed forager-horticultural population. American Journal of Physical Anthropology, 161(3), 494-505.
van Anders, S. M., Goldey, K. L., & Kuo, P. X. (2011). The steroid/peptide theory of social bonds: Integrating testosterone and peptide responses for classifying social behavioral contexts. Psychoneuroendocrinology, 36(9), 1265-1275.
Wisman, A., Heijnen, S., Terol, C., Lu, M., & Finkenauer, C. (2022). Using testosterone to identify subtle differences in social status hierarchies. European Journal of Social Psychology.
Wu, Y., Clark, L., Zilioli, S., Eisenegger, C., Gillan, C. M., Deng, H., & Li, H. (2018). Single dose testosterone administration modulates emotional reactivity and counterfactual choice in healthy males. Psychoneuroendocrinology, 90, 127-133.
臨床研究と治療応用
Amanatkar, H. R., Chibnall, J. T., Seo, B.-W., Manepalli, J. N., & Grossberg, G. T. (2014). Impact of exogenous testosterone on mood: A systematic review and meta-analysis of randomized placebo-controlled trials. Annals of Clinical Psychiatry, 26(1), 19-32.
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744.
Booth, A., Johnson, D. R., & Granger, D. A. (1999). Testosterone and men's depression: The role of social behavior. Journal of Health and Social Behavior, 40(2), 130-140.
Bouloux, P.-M., Legros, J.-J., Elbers, J. M. H., Geurts, T. B. P., Kaspers, M. J. G. H., Meehan, A. G., & Meuleman, E. J. H. (2013). Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: A 1-year, randomized, placebo-controlled, dose-ranging study. The Aging Male, 16(2), 38-47.
Corona, G., Rastrelli, G., Morgentaler, A., Sforza, A., Mannucci, E., & Maggi, M. (2017). Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function scores. European Urology, 72(6), 1000-1011.
Crawford, E. D., Poage, W., Nyhuis, A., Price, D. A., Dowsett, S. A., & Gelwicks, S. (2016). Measurement of testosterone: How important is a morning blood draw? Current Medical Research and Opinion, 31(10), 1911-1914.
Dean, J. D., McMahon, C. G., Guay, A. T., Morgentaler, A., Althof, S. E., Becher, E. F., Bivalacqua, T. J., Burnett, A. L., Buvat, J., El Meliegy, A., Hellstrom, W. J. G., Jannini, E. A., Maggi, M., McCullough, A., Torres, L. O., & Zitzmann, M. (2015). The International Society for Sexual Medicine's process of care for the assessment and management of testosterone deficiency in adult men. The Journal of Sexual Medicine, 12(8), 1660-1686.
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004). Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism, 89(11), 5462-5468.
Grossmann, M., & Matsumoto, A. M. (2017). A perspective on middle-aged and older men with functional hypogonadism: Focus on holistic management. The Journal of Clinical Endocrinology & Metabolism, 102(3), 1067-1075.
Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., & Wilkinson, P. (2013). Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. The Journal of Sexual Medicine, 10(6), 1612-1627.
Hackett, G., Kirby, M., Edwards, D., Jones, T. H., Wylie, K., Ossei-Gerning, N., David, J., & Muneer, A. (2017). British Society for Sexual Medicine guidelines on adult testosterone deficiency, with statements for UK practice. The Journal of Sexual Medicine, 14(12), 1504-1523.
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016). Treatment of men for "Low Testosterone": A systematic review. PLoS ONE, 11(9), e0162480.
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016). Diagnosis and treatment of testosterone deficiency: Recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine, 13(12), 1787-1804.
Kloner, R. A., Carson, C., Dobs, A., Kopecky, S., & Mohler, E. R. (2016). Testosterone and cardiovascular disease. Journal of the American Heart Association, 5(9), e003559.
Mathers, M. J., Sperling, H., Rübben, H., & Roth, S. (2009). The undescended testis: Diagnosis, treatment and long-term consequences. Deutsches Arzteblatt International, 106(33), 527-532.
Morley, J. E., Perry, H. M., Kevorkian, R. T., & Patrick, P. (2006). Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas, 53(4), 424-429.
Morgentaler, A., Miner, M. M., Caliber, M., Guay, A. T., Khera, M., & Traish, A. M. (2015). Testosterone therapy and cardiovascular risk: Advances and controversies. Mayo Clinic Proceedings, 90(2), 224-251.
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., Hackett, G. I., Hellstrom, W. J., Lim, P., Lunenfeld, B., Mskhalaya, G., Schulman, C. C., & Torres, L. O. (2016). Fundamental concepts regarding testosterone deficiency and treatment: International Expert Consensus Resolutions. Mayo Clinic Proceedings, 91(7), 881-896.
Mulhall, J. P., Trost, L. W., Brannigan, R. E., Kurtz, E. G., Redmon, J. B., Chiles, K. A., Lightner, D. J., Miner, M. M., Murad, M. H., Nelson, C. J., Platz, E. A., Ramanathan, L. V., & Lewis, R. W. (2018). Evaluation and management of testosterone deficiency: AUA guideline. Journal of Urology, 200(2), 423-432.
Pope, H. G., Cohane, G. H., Kanayama, G., Siegel, A. J., & Hudson, J. I. (2003). Testosterone gel supplementation for men with refractory depression: A randomized, placebo-controlled trial. American Journal of Psychiatry, 160(1), 105-111.
Resnick, S. M., Matsumoto, A. M., Stephens-Shields, A. J., Ellenberg, S. S., Gill, T. M., Shumaker, S. A., Pleasants, D. D., Barrett-Connor, E., Bhasin, S., Cauley, J. A., Cella, D., Crandall, J. P., Cunningham, G. R., Ensrud, K. E., Farrar, J. T., Lewis, C. E., Molitch, M. E., Pahor, M., Swerdloff, R. S., … Snyder, P. J. (2017). Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA, 317(7), 717-727.
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., Ensrud, K. E., Lewis, C. E., Farrar, J. T., Cella, D., Rosen, R. C., Pahor, M., Crandall, J. P., Molitch, M. E., Cifelli, D., … Ellenberg, S. S. (2016). Effects of testosterone treatment in older men. New England Journal of Medicine, 374(7), 611-624.
Spitzer, M., Huang, G., Basaria, S., Travison, T. G., & Bhasin, S. (2013). Risks and benefits of testosterone therapy in older men. Nature Reviews Endocrinology, 9(7), 414-424.
Traish, A. M., Haider, A., Doros, G., & Saad, F. (2014). Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study. International Journal of Clinical Practice, 68(3), 314-329.
新興技術と将来展望
Basaria, S. (2013). Male hypogonadism. The Lancet, 383(9924), 1250-1263.
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010). Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 95(6), 2536-2559.
Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2017). Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor. The Journal of Clinical Endocrinology & Metabolism, 89(5), 2179-2184.
Crawford, E. D., Schally, A. V., Pinthus, J. H., Block, N. L., Rick, F. G., Garnick, M. B., Eckel, R. H., Keane, T. E., Shore, N. D., Dahdal, D. N., Beveridge, T. J. R., & Marshall, D. C. (2017). The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. Urologic Oncology: Seminars and Original Investigations, 35(5), 183-191.
Dalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., Morton, R. A., & Steiner, M. S. (2011). The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: Results of a double-blind, placebo-controlled phase II trial. Journal of Cachexia, Sarcopenia and Muscle, 2(3), 153-161.
Dobs, A. S., Boccia, R. V., Croot, C. C., Gabrail, N. Y., Dalton, J. T., Hancock, M. L., Johnston, M. A., & Steiner, M. S. (2013). Effects of enobosarm on muscle wasting and physical function in patients with cancer: A double-blind, randomised controlled phase 2 trial. The Lancet Oncology, 14(4), 335-345.
Eisenegger, C., Naef, M., Snozzi, R., Heinrichs, M., & Fehr, E. (2010). Prejudice and truth about the effect of testosterone on human bargaining behaviour. Nature, 463(7279), 356-359.
Gårevik, N., Rane, A., Björkhem-Bergman, L., & Ekström, L. (2014). Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men. Substance Abuse and Rehabilitation, 5, 121-127.
Hackett, G., Cole, N., Saghir, A., Jones, P., Strange, R. C., & Ramachandran, S. (2016). Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: Results from a 30-week randomized placebo-controlled study. BJU International, 118(5), 804-813.
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., & Channer, K. S. (2011). Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care, 34(4), 828-837.
Kawahara, M., Hitomi, Y., & Yokoi, T. (2022). Development of a biomarker assay for testosterone levels using CRISPR/Cas technology. Biochimica et Biophysica Acta (BBA) - General Subjects, 1866(1), 130043.
Kloner, R. A., Carson, C., Dobs, A., Kopecky, S., & Mohler, E. R. (2016). Testosterone and cardiovascular disease. Journal of the American Heart Association, 5(9), e003559.
Miller, K. K., Meenaghan, E., Lawson, E. A., Misra, M., Gleysteen, S., Schoenfeld, D., Herzog, D., & Klibanski, A. (2011). Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study. The Journal of Clinical Endocrinology & Metabolism, 96(7), 2081-2088.
Ponce, O. J., Spencer-Bonilla, G., Alvarez-Villalobos, N., Serrano, V., Singh-Ospina, N., Rodriguez-Gutierrez, R., Salcido-Montenegro, A., Benkhadra, R., Prokop, L. J., Bhasin, S., & Brito, J. P. (2018). The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: A systematic review and meta-analysis of randomized, placebo-controlled trials. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1745-1754.
Russomanno, G., Corbi, G., Amato, B., Liberto, V. D., Trimarco, B., Grieco, A., Formisano, R., Rosa, R. D., Filippelli, A., & Conti, V. (2021). Testosterone replacement therapy prevents sarcopenia in hypogonadal men: From bench to bedside. Life, 11(12), 1393.
Sharma, R., Oni, O. A., Gupta, K., Chen, G., Sharma, M., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Ambrose, J. A., & Barua, R. S. (2015). Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. European Heart Journal, 36(40), 2706-2715.
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., Ensrud, K. E., Lewis, C. E., Farrar, J. T., Cella, D., Rosen, R. C., Pahor, M., Crandall, J. P., Molitch, M. E., Cifelli, D., … Ellenberg, S. S. (2016). Effects of testosterone treatment in older men. New England Journal of Medicine, 374(7), 611-624.
Storer, T. W., Basaria, S., Traustadóttir, T., Harman, S. M., Pencina, K., Li, Z., Travison, T. G., Miciek, R., Tsitouras, P., Hally, K., Huang, G., & Bhasin, S. (2017). Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men. Journal of Clinical Endocrinology & Metabolism, 102(2), 583-593.
Swerdloff, R. S., Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Longstreth, J., & Berman, N. (2000). Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. The Journal of Clinical Endocrinology & Metabolism, 85(12), 4500-4510.
Wilson, C. (2022). Transmasculine health: Testosterone implant offers a different approach. New Scientist, 253(3372), 19.
Zhang, L., Wu, S., Ruan, Y., Hong, L., Xing, X., & Lai, W. (2020). Testosterone and cognitive function in ageing men: A narrative review. Reviews in the Neurosciences, 32(1), 79-92.
レビュー論文とメタ分析
Araujo, A. B., Esche, G. R., Kupelian, V., O'Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007). Prevalence of symptomatic androgen deficiency in men. The Journal of Clinical Endocrinology & Metabolism, 92(11), 4241-4247.
Bassil, N., Alkaade, S., & Morley, J. E. (2009). The benefits and risks of testosterone replacement therapy: A review. Therapeutics and Clinical Risk Management, 5, 427-448.
Braun, S. R. (2021). Promoting "low T": A medical writer's perspective. Journal of Medical Ethics, 47(4), 260-264.
Buvat, J., Maggi, M., Guay, A., & Torres, L. O. (2013). Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. The Journal of Sexual Medicine, 10(1), 245-284.
Corona, G., Rastrelli, G., Maggi, M., & Sforza, A. (2015). Testosterone replacement therapy: Long-term safety and efficacy. World Journal of Men's Health, 33(3), 137-142.
Cunningham, G. R. (2015). Testosterone replacement therapy for late-onset hypogonadism. Nature Reviews Urology, 3(6), 309-315.
Dohle, G. R., Arver, S., Bettocchi, C., Jones, T. H., & Kliesch, S. (2020). EAU guidelines on male hypogonadism. The European Association of Urology.
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., Erwin, P. J., Bhasin, S., & Montori, V. M. (2010). Clinical review 1: Adverse effects of testosterone therapy in adult men: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 95(6), 2560-2575.
Gao, W., & Dalton, J. T. (2007). Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discovery Today, 12(5-6), 241-248.
Heidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., & Mottet, N. (2014). EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013. European Urology, 65(1), 124-137.
Kloner, R. A., Carson, C., Dobs, A., Kopecky, S., & Mohler, E. R. (2016). Testosterone and cardiovascular disease. Journal of the American Heart Association, 5(9), e003559.
Kohn, T. P., & Pastuszak, A. W. (2020). Testosterone therapy in 2020: When, how and in whom? Translational Andrology and Urology, 9(Suppl 2), S166-S177.
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male, 18(1), 5-15.
Mooradian, A. D., & Korenman, S. G. (2006). Management of the cardinal features of andropause. American Journal of Therapeutics, 13(2), 145-160.
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., Hackett, G. I., Hellstrom, W. J., Lim, P., Lunenfeld, B., Mskhalaya, G., Schulman, C. C., & Torres, L. O. (2016). Fundamental concepts regarding testosterone deficiency and treatment: International Expert Consensus Resolutions. Mayo Clinic Proceedings, 91(7), 881-896.
Nieschlag, E., & Nieschlag, S. (2014). Testosterone deficiency: A historical perspective. Asian Journal of Andrology, 16(2), 161-168.
Petering, R. C., & Brooks, N. A. (2017). Testosterone therapy: Review of clinical applications. American Family Physician, 96(7), 441-449.
Roy, C. N., Snyder, P. J., Stephens-Shields, A. J., Artz, A. S., Bhasin, S., Cohen, H. J., Farrar, J. T., Gill, T. M., Zeldow, B., Cella, D., Barrett-Connor, E., Cauley, J. A., Crandall, J. P., Cunningham, G. R., Ensrud, K. E., Lewis, C. E., Matsumoto, A. M., Molitch, M. E., Pahor, M., … Ellenberg, S. S. (2017). Association of testosterone levels with anemia in older men: A controlled clinical trial. JAMA Internal Medicine, 177(4), 480-490.
Skinner, J. W., Otzel, D. M., Bowser, A., Nargi, D., Agellon, S., Girardi, M., Harasim, J., Petrakis, A., Petrukhin, E., Thornhill, L. A., Rajaram, R., Vivas, A., Cutrell, L., Affuso, O., Sadasivan, S., Kamen, D., Wilson, B., Jain, S., Pankow, M., … Borst, S. E. (2018). Muscular responses during testosterone replacement therapy in HIV-infected men. The Journal of Sexual Medicine, 15(2), 210-216.
Traish, A. M. (2014). Adverse health effects of testosterone deficiency (TD) in men. Toxicologic Pathology, 42(1), 88-105.
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., Giwercman, A., Han, T. S., Kula, K., Lean, M. E. J., Pendleton, N., Punab, M., Boonen, S., Vanderschueren, D., Labrie, F., & Huhtaniemi, I. T. (2010). Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine, 363(2), 123-135.